Pernille Neve Myers

Pernille Neve Myers

Auto-generated profile, based on publicly available information

Pernille Neve Myers

Department of Biotechnology and Biomedicine, Technical University of Denmark, Kgs. Lyngby, Denmark

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2021 in Nature
Verified
Journal Article
Closed access
PDF file
LCLuis Pedro Coelho
Luis Pedro Coelho
RARenato Alves
Renato Alves
ARAlvaro Rodriguez del RIo
Alvaro Rodriguez del RIo
PMPernille Neve Myers
Pernille Neve Myers
CCCarlos P. Cantalapiedra
Carlos P. Cantalapiedra
PBPeer Bork
Peer Bork

31 October 2023 in Applied and Environmental Microbiology
Verified
Journal Article
Closed access
MRMette E. Rønne
Mette E. Rønne
TTTobias Tandrup
Tobias Tandrup
MMMikkel Madsen
Mikkel Madsen
CHCameron J. Hunt
Cameron J. Hunt
PMPernille N. Myers
Pernille N. Myers
BSBirte Svensson
Birte Svensson
Humans consume alginate in the form of seaweed, food hydrocolloids, and encapsulations, making the digestion of this mannuronic acid (M) and guluronic acid (G) polymer of key interest for human health. To increase knowledge on alginate degradation in the gut, a gene catalog from human feces was mined for potential alginate lyases (ALs). The predicted ALs were present in nine species of the Bacteroidetes phylum, of which two required supplementation of an endo -acting AL, expected to mimic cross-feeding in the gut. However, only a new isolate grew on alginate. Whole-genome sequencing of this alginate-utilizing isolate suggested that it is a new Bacteroides ovatus strain harboring a polysaccharide utilization locus (PUL) containing three ALs of families: PL6, PL17, and PL38. The Bo PL6 degraded polyG to oligosaccharides of DP 1–3, and Bo PL17 released 4,5-unsaturated monouronate from polyM. Bo PL38 degraded both alginates, polyM, polyG, and polyMG, in endo -mode; hence, it was assumed to deliver oligosaccharide substrates for Bo PL6 and Bo PL17, corresponding well with synergistic action on alginate. Bo PL17 and Bo PL38 crystal structures, determined at 1.61 and 2.11 Å, respectively, showed (α/α) 6 -barrel + anti-parallel β-sheet and (α/α) 7 -barrel folds, distinctive for these PL families. Bo PL17 had a more open active site than the two homologous structures. Bo PL38 was very similar to the structure of an uncharacterized PL38, albeit with a different triad of residues possibly interacting with substrate in the presumed active site tunnel. Altogether, the study provides unique functional and structural insights into alginate-degrading lyases of a PUL in a human gut bacterium. IMPORTANCE: Human ingestion of sustainable biopolymers calls for insight into their utilization in our gut. Seaweed is one such resource with alginate, a major cell wall component, used as a food hydrocolloid and for encapsulation of pharmaceuticals and probiotics. Knowledge is sparse on the molecular basis for alginate utilization in the gut. We identified a new Bacteroides ovatus strain from human feces that grew on alginate and encoded three alginate lyases in a gene cluster. Bo PL6 and Bo PL17 show complementary specificity toward guluronate (G) and mannuronate (M) residues, releasing unsaturated oligosaccharides and monouronic acids. Bo PL38 produces oligosaccharides degraded by Bo PL6 and Bo PL17 from both alginates, G-, M-, and MG-substrates. Enzymatic and structural characterization discloses the mode of action and synergistic degradation of alginate by these alginate lyases. Other bacteria were cross-feeding on alginate oligosaccharides produced by an endo-acting alginate lyase. Hence, there is an interdependent community in our guts that can utilize alginate.

24 June 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
APAnders Ø Petersen
Anders Ø Petersen
HJHanna Julienne
Hanna Julienne
THTuulia Hyötyläinen
Tuulia Hyötyläinen
Partho SenPartho Sen
Partho Sen
YFYong Fan
Yong Fan
OPOluf Pedersen
Oluf Pedersen
Knowledge about in vivo effects of human circulating C-6 hydroxylated bile acids (BAs), also called muricholic acids, is sparse. It is unsettled if the gut microbiome might contribute to their biosynthesis. Here, we measured a range of serum BAs and related them to markers of human metabolic health and the gut microbiome. We examined 283 non-obese and obese Danish adults from the MetaHit study. Fasting concentrations of serum BAs were quantified using ultra-performance liquid chromatography-tandem mass-spectrometry. The gut microbiome was characterized with shotgun metagenomic sequencing and genome-scale metabolic modeling. We find that tauro- and glycohyocholic acid correlated inversely with body mass index (P = 4.1e-03, P = 1.9e-05, respectively), waist circumference (P = 0.017, P = 1.1e-04, respectively), body fat percentage (P = 2.5e-03, P = 2.3e-06, respectively), insulin resistance (P = 0.051, P = 4.6e-4, respectively), fasting concentrations of triglycerides (P = 0.06, P = 9.2e-4, respectively) and leptin (P = 0.067, P = 9.2e-4). Tauro- and glycohyocholic acids, and tauro-a-muricholic acid were directly linked with a distinct gut microbial community primarily composed of Clostridia species (P = 0.037, P = 0.013, P = 0.027, respectively). We conclude that serum conjugated C-6-hydroxylated BAs associate with measures of human metabolic health and gut communities of Clostridia species. The findings merit preclinical interventions and human feasibility studies to explore the therapeutic potential of these BAs in obesity and type 2 diabetes.

8 December 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
CECarsten Eriksen
Carsten Eriksen
JMJanne Marie Moll
Janne Marie Moll
PMPernille Neve Myers
Pernille Neve Myers
APAna Rosa Almeida Pinto
Ana Rosa Almeida Pinto
NDNiels Banhos Danneskiold-Samsøe
Niels Banhos Danneskiold-Samsøe
SBSusanne Brix
Susanne Brix
Immunoglobulin A (IgA) is acknowledged to play a role in the defence of the mucosal barrier by coating microorganisms. Surprisingly, IgA-deficient humans exhibit few infection-related complications, raising the question if the more specific IgG may help IgM in compensating for the lack of IgA. Here we employ a cohort of IgA-deficient humans, each paired with IgA-sufficient household members, to investigate multi-Ig bacterial coating. In IgA-deficient humans, IgM alone, and together with IgG, recapitulate coating of most bacterial families, despite an overall 3.6-fold lower Ig-coating. Bacterial IgG coating is dominated by IgG1 and IgG4. Single-IgG2 bacterial coating is sparse and linked to enhanced Escherichia coli load and TNF-α. Although single-IgG2 coating is 1.6-fold more prevalent in IgA deficiency than in healthy controls, it is 2-fold less prevalent than in inflammatory bowel disease. Altogether we demonstrate that IgG assists IgM in coating of most bacterial families in the absence of IgA and identify single-IgG2 bacterial coating as an inflammatory marker.

16 December 2023 in Gut
Verified
Journal Article
Closed access
PDF file
CECarsten Eriksen
Carsten Eriksen
NDNiels Banhos Danneskiold-Samsøe
Niels Banhos Danneskiold-Samsøe
JMJanne Marie Moll
Janne Marie Moll
PMPernille Neve Myers
Pernille Neve Myers
PBPi W Bondegaard
Pi W Bondegaard
SBSusanne Brix
Susanne Brix
Objective: Patients with Crohn’s disease (CD) exhibit great heterogeneity in disease presentation and treatment responses, where distinct gut bacteria and immune interactions may play part in the yet unresolved disease aetiology. Given the role of antibodies in the barrier defence against microbes, we hypothesised that gut bacterial antibody-coating patterns may influence underlying disease-mediated processes.Design: Absolute and relative single and multicoating of gut bacteria with IgA, IgG1, IgG2, IgG3 and IgG4 in patients with CD and healthy controls were characterised and compared with disease activity. IgG2-coated and non-coated taxa from patients with severe CD were identified, profiled for pathogenic characteristics and monitored for enrichment during active disease across cohorts.Results: Patients with severe CD exhibited higher gut bacterial IgG2-coating. Supervised clustering identified 25 bacteria to be enriched in CD patients with high IgG2-coating. Sorting, sequencing andin silico-based assessments of the virulent potential of IgG2-coated and bulk stool bacteria were performed to evaluate the nature and pathogenicity of IgG2-coated and non-coated bacteria. The analyses demonstrated IgG2-coating of both known pathogenic and non-pathogenic bacteria that co-occurred with two non-coated pathobionts,CampylobacterandMannheimia. The two non-coated pathobionts exhibited low prevalence, rarely coincided and were strongly enriched during disease flares in patients with CD across independent and geographically distant cohorts.Conclusion: Distinct gut bacterial IgG2-coating was demonstrated in patients with severe CD and during disease flares. Co-occurrence of non-coated pathobionts with IgG2-coated bacteria points to an uncontrolled inflammatory condition in severe CD mediated via escape from antibody coating by two gut pathobionts.

19 February 2026 in Clinical Nutrition
Verified
Journal Article
Open access
PMPernille Neve Myers
Pernille Neve Myers
IBInge A.L.P. van Beijsterveldt
Inge A.L.P. van Beijsterveldt
SSStuart G. Snowden
Stuart G. Snowden
CECarsten Eriksen
Carsten Eriksen
HNHenrik Bjørn Nielsen
Henrik Bjørn Nielsen
SBSusanne Brix
Susanne Brix
Exclusive breastfeeding offers numerous health benefits. Despite advancements in formula, significant differences compared with breast milk remain. We aimed to assess how milk feeding type and volume at 3 months affect the infant plasma lipidome and gut microbiota. Infants were classified into exclusive breastfeeding (EBF), mixed feeding (MF), or exclusive formula feeding (EFF) groups based on feeding data collected prospectively across two European cohorts (n = 519). Lipidomics and shotgun metagenomics were applied to plasma and stool samples, respectively. Feeding type explained major variation in both lipidomic and microbial profiles. Plasma lipids showed distinct signatures across groups, particularly in sphingomyelins and diacylglycerols. Microbiota diversity and species richness increased with formula exposure. Formula rich in intact whey protein was linked to higher S. thermophilus abundance in the infant gut. Random forest classification of feeding type using either lipidomic or gut microbiota features achieved high discriminatory accuracy (AUROC >0.90) in training and validation datasets. Early nutrition is a critical determinant of the lipidome and gut microbiome during the breastfeeding phase.